Trial intelligence / Profile preview

Comparison of efficacy and safety of 0.01% bimatoprost and 0.1% tacrolimus in the treatment of facial vitiligo

TCTR20161008001Recruiting

Sponsor

Ramathibodi Hospital

Start

Aug 2016

Modality

RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules

Countries

1